Early Detection of Opioid Over-Procurement: A Semisupervised Machine Learning Approach

Problem definition: The misuse of prescription opioids over the past two decades has emerged as a leading factor contributing to the decline in life expectancy in the United States. This study introduces a machine learning model designed to identify instances of illegal diversion within the prescription drug supply chain in the United States. Methodology/results: We introduce a semisupervised machine learning model aimed at identifying pharmacies involved in excessive procurement of prescription opioids. The model incorporates spatio-temporal and contextual factors, including geographic heterogeneity, supply chain information, and order transactions, to classify whether a retail pharmacy is engaged in opioid overprocurement. To train and evaluate the model, we utilize the Automation of Reports and Consolidated Orders System, a data set maintained by the Drug Enforcement Administration (DEA) that tracks the movement of controlled substances from manufacturing to retail sale. Ground-truth labels indicating improper opioid purchasing behavior are obtained from various sources, including legal proceedings and investigative reports. By comparing our model with three established DEA rules for detecting suspicious orders, we reveal the limitations of these rules, characterized by high rates of false positives and false negatives. In contrast, our semisupervised model achieves accurate identification of suspicious opioid buyers engaged in improper purchasing behavior, with an area under the curve of 0.87. Managerial implications: Our analysis reveals that the buyers identified by our model tend to cluster geographically and have common upstream distributors/manufacturers. This finding underscores the importance of local supply chain networks in facilitating the illicit distribution of prescription opioids. In terms of implementation, models similar to the one proposed in this paper can leverage the DEA’s existing infrastructure to identify and alert unusual opioid distribution patterns.

Authors

Institutions

Publication Details

Journal
Manufacturing & Service Operations Management
Published
2025-08-11
DOI
https://doi.org/10.1287/msom.2020.0369
Citations
1
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Detection of Opioid Over-Procurement: A Semisupervised Machine Learning Approach

Dimitris Bertsimas, Periklis Petridis, Joshua Ivanhoe, Mohammad M. Fazel‐Zarandi
1 citations
Manufacturing & Service Operations Management
Opioid Use Disorder Treatment
1.88
article

Early Detection of Opioid Over-Procurement: A Semisupervised Machine Learning Approach

Dimitris Bertsimas, Periklis Petridis, Joshua Ivanhoe, Mohammad M. Fazel‐Zarandi
article en
1 citations

Abstract

Problem definition: The misuse of prescription opioids over the past two decades has emerged as a leading factor contributing to the decline in life expectancy in the United States. This study introduces a machine learning model designed to identify instances of illegal diversion within the prescription drug supply chain in the United States. Methodology/results: We introduce a semisupervised machine learning model aimed at identifying pharmacies involved in excessive procurement of prescription opioids. The model incorporates spatio-temporal and contextual factors, including geographic heterogeneity, supply chain information, and order transactions, to classify whether a retail pharmacy is engaged in opioid overprocurement. To train and evaluate the model, we utilize the Automation of Reports and Consolidated Orders System, a data set maintained by the Drug Enforcement Administration (DEA) that tracks the movement of controlled substances from manufacturing to retail sale. Ground-truth labels indicating improper opioid purchasing behavior are obtained from various sources, including legal proceedings and investigative reports. By comparing our model with three established DEA rules for detecting suspicious orders, we reveal the limitations of these rules, characterized by high rates of false positives and false negatives. In contrast, our semisupervised model achieves accurate identification of suspicious opioid buyers engaged in improper purchasing behavior, with an area under the curve of 0.87. Managerial implications: Our analysis reveals that the buyers identified by our model tend to cluster geographically and have common upstream distributors/manufacturers. This finding underscores the importance of local supply chain networks in facilitating the illicit distribution of prescription opioids. In terms of implementation, models similar to the one proposed in this paper can leverage the DEA’s existing infrastructure to identify and alert unusual opioid distribution patterns.

Manufacturing & Service Operations ManagementVol. 27(6)
Massachusetts Institute of Technology (US)
Industry, innovation and infrastructure
Openalex Percentile: Top 13%
Opioid Use Disorder Treatment
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.